0
0
0
340B PATIENTS Act of 2024
9/24/2024, 3:53 AM
Summary of Bill S 5021
The 340B PATIENTS Act of 2024, also known as Bill 118 s 5021, is a piece of legislation currently being considered by the US Congress. This bill aims to address issues related to the 340B Drug Pricing Program, which allows certain healthcare providers to purchase prescription drugs at discounted prices.
The main goal of the 340B PATIENTS Act is to increase transparency and accountability within the program. The bill includes provisions that require participating healthcare providers to report on how they are using the savings they receive from discounted drug prices. This information will be made publicly available in order to ensure that the program is being used in a way that benefits patients and the healthcare system as a whole.
Additionally, the bill seeks to address concerns about the potential for abuse and misuse of the 340B program. It includes measures to strengthen oversight and enforcement mechanisms, as well as provisions to prevent drug manufacturers from discriminating against certain healthcare providers who participate in the program. Overall, the 340B PATIENTS Act of 2024 aims to improve the effectiveness and integrity of the 340B Drug Pricing Program, ultimately benefiting patients and ensuring that the program is being used in a responsible and ethical manner.
The main goal of the 340B PATIENTS Act is to increase transparency and accountability within the program. The bill includes provisions that require participating healthcare providers to report on how they are using the savings they receive from discounted drug prices. This information will be made publicly available in order to ensure that the program is being used in a way that benefits patients and the healthcare system as a whole.
Additionally, the bill seeks to address concerns about the potential for abuse and misuse of the 340B program. It includes measures to strengthen oversight and enforcement mechanisms, as well as provisions to prevent drug manufacturers from discriminating against certain healthcare providers who participate in the program. Overall, the 340B PATIENTS Act of 2024 aims to improve the effectiveness and integrity of the 340B Drug Pricing Program, ultimately benefiting patients and ensuring that the program is being used in a responsible and ethical manner.
Read the Full Bill
Current Status of Bill S 5021
Bill S 5021 is currently in the status of Bill Introduced since September 11, 2024. Bill S 5021 was introduced during Congress 118 and was introduced to the Senate on September 11, 2024. Bill S 5021's most recent activity was Read twice and referred to the Committee on Health, Education, Labor, and Pensions. as of September 11, 2024
Bipartisan Support of Bill S 5021
Total Number of Sponsors
1Democrat Sponsors
1Republican Sponsors
0Unaffiliated Sponsors
0Total Number of Cosponsors
2Democrat Cosponsors
2Republican Cosponsors
0Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill S 5021
Primary Policy Focus
Alternate Title(s) of Bill S 5021
340B PATIENTS Act of 2024
340B PATIENTS Act of 2024
340B Pharmaceutical Access To Invest in Essential, Needed Treatments & Support Act of 2024
A bill to ensure the accessibility of drugs furnished through the drug discount program under section 340B of the Public Health Service Act.
Comments
Sponsors and Cosponsors of S 5021
Latest Bills
Foster Youth Housing Opportunity Act
Bill HR 7432May 14, 2026
A bill to amend the National Defense Authorization Act for Fiscal Year 2021 to prohibit certain institutions of higher education from receiving research and development awards, and for other purposes.
Bill S 4424May 14, 2026
Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Fair Credit Reporting; Permissible Purposes for Furnishing, Using, and Obtaining Consumer Reports".
Bill HJRES 165May 14, 2026
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Fair Credit Reporting; Permissible Purposes for Furnishing, Using, and Obtaining Consumer Reports".
Bill SJRES 145May 14, 2026
Amending the Rules of the House of Representatives to prohibit Members, officers, and employees of the House of Representatives from participating in prediction markets in certain cases, and for other purposes.
Bill HRES 1248May 14, 2026
Ending Discrimination in Government Contracting Act
Bill HR 8511May 14, 2026
Ending Discrimination in Government Contracting Act
Bill S 4390May 14, 2026
To designate the facility of the United States Postal Service located at 201 East Grant Avenue in Georgetown, Ohio, as the "Ulysses S. Grant Post Office Building".
Bill HR 7809May 14, 2026
To designate the facility of the United States Postal Service located at 111 South Tremont Street in Tremonton, Utah, as the "Sorensen-Estrada Post Office".
Bill HR 8225May 14, 2026
To designate the facility of the United States Postal Service located at 189 East Main Street in Xenia, Ohio, as the "Gilman 'Gil' Whitney Post Office Building".
Bill HR 8193May 14, 2026